Join STAT on Dec. 7 for an evening event as we gather medical and industry experts.
Some featured speakers and early sessions have been announced here, including Sickle Cell at a Crossroads, a panel moderated by STAT senior biotech writer Adam Feuerstein — exploring the challenges gene-editing treatments for sickle cell disease face, including slow adoption and the complexities of treatment delivery.
Join Adam alongside leading voices Dr. Titilope Fasipe, of Texas Children's Hospital and Baylor College of Medicine; Dr. Julie Kanter, of the University of Alabama at Birmingham and the National Alliance of Sickle Cell Centers; and Teonna Woolford, of the Sickle Cell Reproductive Health Education Directive, as they discuss the future of sickle cell care.
Stay tuned for the release of the final STAT@ASH agenda— coming soon.
This event is free to attend. RSVP to reserve your spot!
No comments